LIPIVIEW
LIVE

Serial Number

77384342

Owner

TEARSCIENCE, INC.

Attorney

Marci A. Blazer

First Use Date

Oct 15, 2010

Filing Date

Jan 30, 2008

Add to watchlist:

No watchlists yet
View on USPTO

LIPIVIEW Trademark

Serial Number: 77384342 • Registration: 3917406

LIPIVIEW is a trademark filed by TEARSCIENCE, INC. on January 30, 2008. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

TEARSCIENCE, INC. (7 trademarks)

Milpitas, NJ 95035

Entity Type: 03

Kolis Scientific, Inc. (5 trademarks)

1101 G Aviation Parkway
Morrisville, NC 27560

Entity Type: 03

Trademark Details

Filing Date

January 30, 2008

Registration Date

February 8, 2011

First Use Anywhere

October 15, 2010

First Use in Commerce

October 15, 2010

Published for Opposition

September 9, 2008

Goods & Services

[ Education services, namely, classes, conferences, seminars, workshops, in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Education services, namely, providing seminars, tutorials, workshops for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; Training services in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Training services, namely, providing seminars, tutorials, workshops for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction ]

Computer hardware and software, and parts and accessories therefor, for use with apparatus for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction

[ Printed instructional, educational and teaching materials in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Printed instructional, educational and teaching materials for analysis, diagnosis, treatment, and monitoring of eye disease, namely, dry eye and meibomian gland dysfunction ]

[ Medical services, namely, providing medical analysis, diagnosis, treatment, and monitoring of eye diseases and conditions; Medical services, namely, providing medical analysis, diagnosis, treatment, and monitoring of dry eye and meibomian gland dysfunction; ] Providing medical information related to eye disease, namely, dry eye and meibomian gland dysfunction, for educational purposes

Medical apparatuses and devices, and parts and accessories therefor, used for analyzing [, diagnosing, treating, ] and monitoring eye disease, namely, dry eye and meibomian gland dysfunction;[ Medical device, and parts and accessories therefor, for expressing obstructions or occlusions from meibomian glands; Medical heater used primarily for medical purposes, namely, for applying heat to a patient's eye and related eye structure for treating eye diseases, namely, dry eye and meibomian gland dysfunction; Medical devices, namely, medical contact lens used primarily for medical purposes containing an electrical heating element for applying heat to meibomian glands when installed on a patient's eye for treating dry eye and meibomian gland dysfunction; ] Optical and photographic apparatus and instruments, and parts and accessories therefor, namely, interferometers and cameras, for analyzing, diagnosing, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; medical imaging apparatuses and devices comprising optical lens, camera, lamp, LED, spectrometer, used for analyzing, diagnosing, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction [ ; electronic medical temperature controller, and parts and accessories therefor, used primarily for temperature controller purposes, namely, for delivering and controlling heat to meibomian glands for use in treating eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical pressure controller, and parts and accessories therefor, used primarily for controlling pressure, namely, for applying and controlling pressure to the meibomian glands for use in treating eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical fluid transfer controller, and parts and accessories therefor, used primarily for controlling and transferring heated fluid to the eye for use in treating eye disease, namely, dry eye and meibomian gland dysfunction ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
May 16, 2021 NAS8
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 16, 2021 RNL1
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
May 16, 2021 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
May 16, 2021 8PRT
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 16, 2021 APRE
TEAS SECTION 8 & 9 RECEIVED
Feb 5, 2021 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 8, 2020 REM2
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 11, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 11, 2018 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 6, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 6, 2018 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 16, 2016 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 16, 2016 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 16, 2016 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 8, 2016 E815
REGISTERED-PRINCIPAL REGISTER
Feb 8, 2011 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Jan 6, 2011 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jan 5, 2011 REGV
ASSIGNED TO LIE
Jan 4, 2011 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 15, 2010 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 7, 2010 SUPC
USE AMENDMENT FILED
Dec 2, 2010 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 2, 2010 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Jun 8, 2010 EXRA
SOU EXTENSION 3 GRANTED
Jun 7, 2010 EX3G
SOU EXTENSION 3 FILED
Jun 2, 2010 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 2, 2010 EEXT
SOU EXTENSION 2 GRANTED
Jan 15, 2010 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 14, 2010 AITU
SOU EXTENSION 2 FILED
Nov 24, 2009 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 24, 2009 EEXT
ASSIGNED TO EXAMINER
May 15, 2009 DOCK
SOU EXTENSION 1 GRANTED
May 6, 2009 EX1G
SOU EXTENSION 1 FILED
May 6, 2009 EXT1
SOU TEAS EXTENSION RECEIVED
May 6, 2009 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 14, 2009 ASGN
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 2, 2008 NOAM
PUBLISHED FOR OPPOSITION
Sep 9, 2008 PUBO
NOTICE OF PUBLICATION
Aug 20, 2008 NPUB
EXAMINERS AMENDMENT MAILED
Aug 8, 2008 CNEA
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 7, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 7, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 7, 2008 XAEC
EXAMINERS AMENDMENT -WRITTEN
Aug 7, 2008 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 4, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 1, 2008 PBCR
EXAMINERS AMENDMENT MAILED
Jul 21, 2008 CNEA
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 18, 2008 PREV
ASSIGNED TO LIE
Jul 18, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 18, 2008 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jul 18, 2008 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2008 TROA
NON-FINAL ACTION MAILED
May 12, 2008 CNRT
NON-FINAL ACTION WRITTEN
May 9, 2008 CNRT
ASSIGNED TO EXAMINER
May 8, 2008 DOCK
NEW APPLICATION ENTERED
Feb 4, 2008 NWAP